Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

76.45 0.86 −1.11%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100

Alcon (ALC) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Alcon (ALC) trades at a P/E ratio of 58.4×. Over the past ten years it has ranged from 0.0× (June 2021) to 236× (September 2021); the current reading is higher than 72% of that period. That is above the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 39.6× (4.36%)
FY2024 41.4× 5.89%
FY2023 39.1× (61.45%)
FY2022 101× (11.03%)
FY2021 114× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 21.7× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 51.2× 13.52%
Mar 2026 45.1× 13.93%
Dec 2025 39.6× 12.68%
Sep 2025 35.1× (13.61%)
28 more quarters

Against its own ten years

Low 0.0× High 236×
Ten-year median 39.6×
Current reading's percentile 56

P/E ratio against peers

Company P/E ratio
BAX Baxter International Inc. compare n/m
COO The Cooper Companies, Inc. compare 21.7×
RMD ResMed Inc. compare 21.7×
ALGN Align Technology, Inc. compare 23.1×
WST West Pharmaceutical Services, Inc. compare 43.8×
ALC Alcon 58.4×
MDLN Medline Inc. compare 58.4×
BDX Becton, Dickinson and Company compare 64.1×
SOLV Solventum Corporation compare 97.3×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ALC